Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. [electronic resource]
- Pharmacology & therapeutics Nov 2007
- 192-206 p. digital
Publication Type: Journal Article; Review
0163-7258
10.1016/j.pharmthera.2007.06.013 doi
Animals Chronic Disease Clinical Trials as Topic Drug Evaluation, Preclinical Enzyme Inhibitors--pharmacology Heart Failure--drug therapy Humans Myocardial Ischemia--drug therapy p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors